Innate Pharma (IPHA) analyst forecast and price target
Analyst forecast
Consensus of 4 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $9.00 from $8.00 | Aug 12, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 from $5.00 | Aug 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Apr 7, 2026 |
| BTIG | Initiated Coverage | Buy | $8.00 | Mar 12, 2026 |
| BTIG | Maintained | Buy | $8.00 | Oct 29, 2025 |
| HC Wainwright & Co. | Upgraded | Neutral → Buy | $5.00 | Oct 29, 2025 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | — | Sep 18, 2025 |
| Leerink Partners | Downgraded | Outperform → Market Perform | $2.00 from $10.00 | Sep 18, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 from $11.50 | Apr 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $11.50 | Mar 28, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $11.50 | Feb 6, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $11.50 | Jan 17, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $11.50 | Dec 9, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.50 | Nov 15, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.50 | Nov 12, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.50 | Sep 13, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.50 | Jun 12, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.50 | May 15, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.50 | Apr 11, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.50 | Mar 22, 2024 |
Frequently asked questions
Is IPHA a buy, sell, or hold?
Analysts covering Innate Pharma currently average a Buy rating: 4 buy, 0 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on IPHA?
On Aug 12, 2026, BTIG maintained Innate Pharma at Buy with a price target of $9.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.